about
Genomewide Association Study Identifies Novel Genetic Loci That Modify Antiplatelet Effects and Pharmacokinetics of ClopidogrelPopulation pharmacokinetics and safety of eptifibatide in healthy Chinese volunteers and simulations on the dose regimens approved for a Western population.Simultaneous Determination of Rosuvastatin, Rosuvastatin-5 S-lactone, and N-desmethyl Rosuvastatin in Human Plasma by UPLC-MS/MS and Its Application to Clinical Study.Plasma miR-142 accounting for the missing heritability of CYP3A4/5 functionality is associated with pharmacokinetics of clopidogrel.High Plasma Exposure of Statins Associated With Increased Risk of Contrast-Induced Acute Kidney Injury in Chinese Patients With Coronary Artery Disease.Development and Validation of an HPLC-MS/MS Method for Rapid Simultaneous Determination of Cefprozil Diastereomers in Human PlasmaRapid determination of fenoldopam in human plasma by UPLC-MS/MS for pharmacokinetic analysis in patientsSimultaneous Determination of Ticagrelor and Its Metabolites in Human Plasma and Urine Using Liquid Chromatography-Tandem Mass Spectrometry
P50
Q33837665-59776DD4-A7C7-4C63-8700-0E181A2E1CFFQ40806726-63992BB8-4545-4C27-8A29-E373372E3D15Q49894073-544698ED-2818-4843-80BD-776567659FE3Q51552991-A2A434F4-29ED-48F4-BF7C-0DD46F2E3EC5Q55271067-8AAA3A5A-6782-4A9A-A773-4FE3F8ADACC6Q57300396-569FCCB1-AB33-4600-9488-EF829B717BA3Q86375203-C38E989F-273B-41E7-88C7-E031A0AFE951Q89408451-F7F7219F-26B0-46CC-B914-8ECE74223AB2
P50
description
investigador
@es
researcher
@en
name
Guo-Dong He
@en
type
label
Guo-Dong He
@en
prefLabel
Guo-Dong He
@en
P31
P496
0000-0002-0530-8907